Clinical trial Recruiting at 1 site Interventional Ages 7 to 17

Adapted physical activity program to improve endurance in children and teens with Marfan syndrome

Official title: Marfan&Moves (M&M's) : an Adapted Physical Activity Program (APA) for Effort Rehabilitation of Children and Teenagers With Marfan Syndrome: an Interventional, Prospective, Monocentric Study.

Run by University Hospital, Toulouse · NCT05838235 · Data updated 2026-11-12

This project will try a 6‑month tailored exercise program to see if it improves endurance (VO2 peak) and quality of life in children and teenagers with Marfan syndrome.

Quick facts

Study typeInterventional
Ages7 Years to 17 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity Hospital, Toulouse
Academic / other
Locations1 site (Toulouse)
StatusRecruiting
StartedApril 24, 2023
Main results expectedApril 2028
Study endsOctober 2028
Registry record updatedMarch 3, 2026
Trial IDNCT05838235 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children and teenagers aged 7–17 with genetically confirmed Marfan syndrome who have parental informed consent, are affiliated to a social security scheme or equivalent, and do not have the trial's cardiac contraindications.

Probably not a fit

Patients with severe cardiac involvement (aortic diameter >45 mm, left ventricular ejection fraction <45%, or severe mitral regurgitation ≥ grade 3), pregnant patients, or those unable to participate in the activity program are unlikely to receive benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Marfan syndrome causes connective tissue fragility that often leads to musculoskeletal problems, marked fatigue, and reduced endurance in young patients. This interventional program enrolls genetically confirmed participants aged 7–17 and uses a baseline cardiopulmonary exercise test (CPET) with VO2 peak measurement at the Reference Centre for Marfan syndrome in Toulouse to tailor a 6‑month adapted physical activity (APA) plan. An APA coach designs activities matched to daily life and interests and provides ongoing support to promote adherence and prevent deconditioning. The primary outcome is change in VO2 peak after six months, with secondary assessments of fatigue and quality of life.

Why it matters

Potential benefit: If successful, the program could increase endurance, reduce fatigue, and improve daily functioning and quality of life for children and adolescents with Marfan syndrome.

How similar studies have gone: A prior study (Marfanpower, NCT03236571) found greatly reduced VO2 peak in young people with Marfan syndrome and showed that an intensive rehabilitation program significantly increased endurance, so this adapted program builds on promising earlier results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Genetically confirmed Marfan syndrome or related syndrome
* Girl or boy aged 7 to 17
* Informed and written consent signed by at least one of the two holders of parental authority
* Patient affiliated to a social security scheme or equivalent

Exclusion Criteria:

* Cardiac contraindications to the APA program:

  * Severe aortic dilation (aortic diameter \> 45 mm)
  * and/or left ventricular failure (left ventricular ejection fraction \<45%)
  * and/or severe mitral leakage ≥ grade 3
* Pregnancy

Where it's running

  • CHU Toulouse
    Toulouse, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Pregnancy-Related Aortic Dissection in China

    This study looks at cases of aortic dissection that occur during pregnancy or shortly after, to understand outcomes for mothers and babies.

    Recruiting at 4 sites DeltaHealth Hospital · Shanghai · Shanghai, Shanghai Municipality and 3 other locations · NCT07672210

  • Registry for hereditary cardiovascular diseases in Brazil

    This study is trying to create a registry of Brazilian patients with hereditary heart diseases to see how common certain genetic changes are in people with these conditions.

    Recruiting at 27 sites Hospital do Coracao · Rio Branco, Acre and 26 other locations · NCT06546137

  • Moderate exercise program for adolescents and young adults with Marfan syndrome

    This study is testing whether a moderate exercise program can help teenagers and young adults with Marfan syndrome feel better both physically and mentally.

    Recruiting Baylor College of Medicine · Houston, Texas · NCT05809323

  • Psychological support for adults with Marfan syndrome

    This study looks at why adults with Marfan syndrome seek psychological support and how their condition affects their mental health and coping skills.

    Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Lombardy · NCT05712577

  • Assessing facial features in Marfan syndrome

    This study is trying to identify and track the facial features of people with Marfan syndrome to help with earlier diagnosis and understanding of the condition.

    Recruiting IRCCS Policlinico S. Donato · San Donato Milanese, Lombardy · NCT05702476

  • Collection of biological samples from patients with Marfan syndrome

    This study is collecting blood and urine samples from people with Marfan syndrome to help researchers learn more about the condition and how to improve treatment for patients.

    Recruiting University Hospital, Toulouse · Toulouse · NCT04970459

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.